allergy to glp 1 GLP-1 Drugs: For Multiple Chronic Conditions Dermal Hypersensitivity Reaction to Semaglutide:

Cellular senescence: at the nexus between ageing and diabetes

Liu Zhaozhao (90) reported that liraglutide can activate GLP-1Rs, and that liraglutide can promote the proliferation of breast cancer cells by activating GLP-1Rs

Patients using MOTS-c often report: Increased stamina Better insulin regulation Reduction in belly fat Other Promising Peptides CJC-1295 / Ipamorelin : Stimulate natural growth hormone release , supporting fat loss and lean muscle gain

The oxidative stress causes DNA damage

PUFA-induced metabolic enteritis as a fuel for Crohns disease

Clinical trials of FDA-approved tirzepatide (Zepbound, Mounjaro) have shown average weight loss of 15-20% of body weight over 72 weeks when combined with lifestyle modifications-greater than semaglutide's 12-15% average